Similarly, pre-treatment WBC levels showed a significant influence (p = 0.042, OR not provided, 95%CI = 1.041–9.058), as did the levels of Hs-CRP (p = 0.017, OR = 4.237, 95%CI = 1.537–11.682) (Table 4), underscore the predictive value of these biomarkers in determining the effectiveness of the treatment regimen for stroke neurosyphilis patients (Figure 3). This evidence concerns the gene CRP and stroke disorder.